3 Sep, 2010
ARLINGTON, Tenn.–(BUSINESS WIRE)–Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today that it will be participating in the following upcoming healthcare conferences: Baird’s 2010 Healthcare Conference – Wright’s President and Chief Executive Officer, Gary D. Henley, will present on Tuesday, September 14, 2010 at the St. Regis Hotel in New York City, New York at 12:15 p.m. Eastern Time. Stifel Nicolaus Healthcare Conference 2010 – Wright’s Pres

Link:
Wright Medical Group, Inc. to Participate in Upcoming September 2010 Healthcare Conferences
3 Sep, 2010
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that it is investigating potential claims against Allergan, Inc. (“Allergan” or the “Company”) (NYSE:AGN) concerning possible breaches of fiduciary duty or other violations of law by the Company’s board of directors. Allergan is a multi-specialty healthcare company, engaged in the discovery, development, and commercialization of specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neuro

Read more:
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.
3 Sep, 2010
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that it is investigating potential claims against Allergan, Inc. (“Allergan” or the “Company”) (NYSE:AGN) concerning possible breaches of fiduciary duty or other violations of law by the Company’s board of directors. Allergan is a multi-specialty healthcare company, engaged in the discovery, development, and commercialization of specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neuro

Excerpt from:
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.
2 Sep, 2010
PRINCETON, N.J.–(BUSINESS WIRE)–Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces that all five products in its novel line of XTRASORB® HCS Dressings have received Healthcare Common Procedural Coding System (HCPCS) codes. These codes – A6234 through A6238 – were awarded by the Centers for Medicare and Medicaid Services (CMS), and allow healthcare providers to bill for the dressings beginning immediately. XTRASORB HCS make

Link:
Derma Sciences Novel XTRASORB® HCS Dressings Receive Federal Reimbursement Codes; Join Foam and Classic Dressings for Complete Coverage of Product…
1 Sep, 2010
ST. PAUL, Minn.–(BUSINESS WIRE)–St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 13, in New York City. John C. Heinmiller, executive vice president and chief financial officer, will address the conference at 1:35 p.m. EDT

Read more:
St. Jude Medical To Present at the Morgan Stanley Global Healthcare Conference